37th week of 2013 patent applcation highlights part 50 |
Patent application number | Title | Published |
20130237561 | PHARMACEUTICAL COMPOSITIONS COMPRISING IMIDAZOQUINOLIN(AMINES) AND DERIVATIVES THEREOF SUITABLE FOR LOCAL ADMINISTRATION - The present invention relates in general to the field of modulators of the innate immune system, particularly to pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof, preferably suitable for local administration, such as, intravesical administration. In addition, the present invention concerns the use of imidazoquinolin(amines) and derivatives thereof for intravesical treatment of bladder diseases, such as, for example, bladder cancer and cystitis. The present invention furthermore comprises methods of treatment for these diseases as well as methods of administration of the inventive pharmaceutical compositions. | 2013-09-12 |
20130237562 | PI3 KINASE/mTOR DUAL INHIBITOR - The present invention provides an imidazo[4,5-c]quinolin-2-one compound, or a pharmaceutically acceptable salt thereof, that inhibits both PI3K and mTOR and, therefore, is useful in the treatment of cancer. | 2013-09-12 |
20130237563 | NOVEL POLYMORPHS OF PITAVASTATIN CALCIUM - The present invention provides a solid of pitavastatin tert-butyl ester and process for its preparation. The present invention also provides a novel crystalline form of pitavastatin calcium, process for its preparation and pharmaceutical compositions comprising it. | 2013-09-12 |
20130237564 | Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists - A medicament comprising, separately or together (A) glycopyrrolate; and
| 2013-09-12 |
20130237565 | Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinoli- necarboxamide - A pharmaceutical composition comprising: an active ingredient consisting of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide, salt thereof, or solvate of the foregoing; and (i) a compound, a 5% (w/w) aqueous solution or suspension of which has a pH of 8 or more, and/or (ii) silicic acid, salt thereof, or solvate of the foregoing is a highly stable pharmaceutical composition, wherein under humidified and heated storage conditions, the decomposition of said compound is sufficiently reduced, or the gelation on the surface of the pharmaceutical composition is sufficiently inhibited. | 2013-09-12 |
20130237566 | HETEROCYCLIC COMPOUNDS AS S1P1 AGONISTS FOR THE TREATMENT OF AUTOIMMUNE AND VASCULAR DISEASES - Disclosed are compounds of Formula (I) or stereoisomers, salts, or prodrugs thereof, wherein: W is CH | 2013-09-12 |
20130237567 | IMINOSUGARS AND METHODS OF TREATING VIRAL DISEASES - Provided are methods of treating or preventing viral infections caused by or associated with a Dengue virus using iminosugars. | 2013-09-12 |
20130237568 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS - Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention. | 2013-09-12 |
20130237569 | MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS - Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTC”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention. | 2013-09-12 |
20130237570 | Formulation and Use and Manufacture Thereof - This invention relates to a liquid pharmaceutical formulation for delivering nicotine to a subject. This invention also relates to a method and a system for delivering nicotine as well as manufacturing and use of said liquid pharmaceutical formulation. | 2013-09-12 |
20130237571 | AGONISTS OF GPR40 - The present invention relates to compounds that have the ability to modulate the activity of GPR40 and are therefore useful in the treatment of GPR40 related disorders. In addition the invention relates to the compounds, methods for their preparation, pharmaceutical compositions containing the compounds and the uses of these compounds in the treatment of certain disorders related to GPR40 activity. | 2013-09-12 |
20130237572 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS - Topical formulations and method of using the same are provided. The topical formulation comprises a pyrazolylbenzothiazole derivative of the following formula (1) | 2013-09-12 |
20130237573 | 4-SUBSTITUTED-3-BENZYLOXY-BICYCLO[3.1.0]HEXANE COMPOUNDS AS mGluR 2/3 ANTAGONISTS - A mGlu2/3 receptor antagonist of the formula: | 2013-09-12 |
20130237574 | TABLET FORMULATIONS COMPRISING VALSARTAN - The invention relates to solid oral dosage forms comprising pharmacologically effective amounts of valsartan or a pharmaceutically acceptable salt thereof or hydrate thereof. The compositions are at least 1.2 times more bioavailable than conventional valsartan capsule. | 2013-09-12 |
20130237575 | ANTI-INFECTIVE AGENTS AGAINST INTRACELLULAR PATHOGENS - A new class of phosphoinositide-dependent kinase-1 (PDK-1) inhibitors of Formula I: | 2013-09-12 |
20130237576 | Dexmedetomidine Premix Formulation - The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation. | 2013-09-12 |
20130237577 | COMPOSITIONS COMPRISING AMINO ACIDS FOR PREVENTION AND/OR TREATMENT OF RENAL DISORDERS - Composition comprising leucine, isoleucine, valine, threonine and lysine for use in prophylactic and/or therapeutic treatment of renal disorders in a subject, preferably an elderly subject. | 2013-09-12 |
20130237578 | PHARMACEUTICAL COMPOSITION - The present invention provides compounds of Formula I: | 2013-09-12 |
20130237579 | STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ONE OR MORE HMG-COA REDUCTAS INHIBITIORS - The present invention relates to stable pharmaceutical compositions comprising one or more HMG-CoA reductase inhibitors, processes for preparing the stable compositions and uses for the compositions. The stable pharmaceutical compositions of the invention may be used, in particular, for the treatment of hyperlipoproteinemia and atherosclerosis. | 2013-09-12 |
20130237580 | PEPTIDOMIMETIC COMPOUNDS AS IMMUNOMODULATORS - The present invention relates to novel peptidomimetic compounds as therapeutic agents capable of inhibiting the programmed cell death 1 (PD1) signalling pathway. The invention also relates to derivatives of the therapeutic agents. The invention also encompasses the use of the said therapeutic agents and derivatives for treatment of disorders via immunopotentiation comprising inhibition of immunosuppressive signal induced due to PD-1, PD-L1, or PD-L2 and therapies using them. | 2013-09-12 |
20130237581 | 3-PHENOXYMETHYLPYRROLIDINE COMPOUNDS - In one aspect, the invention relates to compounds of formula I: | 2013-09-12 |
20130237582 | PHARMACEUTICAL COMBINATION OF PACLITAXEL AND A CDK INHIBITOR - The present invention relates to a pharmaceutical combination comprising paclitaxel, or its pharmaceutically acceptable salt; and at least one cyclin dependent kinase (CDK) inhibitor represented by a compound of formula I (as described herein) or a pharmaceutically acceptable salt thereof, for use in the treatment of triple negative breast cancer (TNBC). The present invention relates to a method for the treatment of breast cancer, particularly triple negative breast cancer, by administration to a patient in need thereof, a therapeutically effective amount of a pharmaceutical combination comprising a cytotoxic antineoplastic agent, paclitaxel, and at least one cyclin dependent kinase (CDK) inhibitor; wherein said combination on administration exhibits synergistic effects. | 2013-09-12 |
20130237583 | PROCESS FOR THE PREPARATION OF DIHYDROPYRROLE DERIVATIVES - The present invention provides stereoselective processes for the preparation of compounds of formula (I) wherein P is phenyl, naphthyl, a 6-membered heteroaryl group containing one or two nitrogen atoms as ring members, or a 10-membered bicyclic heteroaryl group containing one or two nitrogen atoms as ring members, and wherein the phenyl, naphthyl and heteroaryl groups are optionally substituted; R | 2013-09-12 |
20130237584 | CANCER THERAPY USING Bcl-XL-SPECIFIC siNA - The invention relates to a double-stranded short interfering nucleic acid (siNA) molecule specific to the Bcl-X | 2013-09-12 |
20130237585 | MODULATION OF DYSTROPHIA MYOTONICA-PROTEIN KINASE (DMPK) EXPRESSION - Provided herein are methods, compounds, and compositions for reducing expression of a DMPK mRNA and protein in an animal. Also provided herein are methods, compounds, and compositions for preferentially reducing CUGexp DMPK RNA, reducing myotonia or reducing spliceopathy in an animal. Such methods, compounds, and compositions are useful to treat, prevent, delay, or ameliorate type 1 myotonic dystrophy, or a symptom thereof. | 2013-09-12 |
20130237586 | DELIVERY OF dsRNA TO ARTHROPODS - The invention is to methods of gene silencing in arthropods using dsRNA. The method is include contacting the arthropod with, and/or directly feeding the arthropod, the dsRNA to the arthropods to deliver the dsRNA to arthropod tissues. It is envisaged that the methods of the invention will have use in determining the biological function of genes in arthropods. Methods of pest control of arthropods, and of protecting arthropods against parasites and predators are provided. Transgenic arthropods expressing dsRNA molecules are also provided by the present invention. | 2013-09-12 |
20130237587 | MIR 204, MIR 211, THEIR ANTI-MIRS, AND THERAPEUTIC USES OF SAME - Embodiments of the invention provide methods of preventing or treating detrimental epithelial cell proliferation, loss of epithelial cell differentiation, age-related macular degeneration and/or proliferative vitreal retinopathy in an individual comprising administering to an individual in need thereof an effective amount of miR 204, an effective amount of miR 211, or an effective amount of a mixture of miR 204 and miR 211. A further embodiment of the invention provides a method of facilitating the transport of a substance across an epithelium in an individual comprising administrating to an individual an effective amount of anti-miR 204, an effective amount of anti-miR 211, or an effective amount of a mixture of anti-miR 204 and anti-miR 211. Additional embodiments of the invention include pharmaceutical compositions of miR 204 and/or miR 211 and pharmaceutical compositions of anti-miR 204 and/or anti-miR 211. | 2013-09-12 |
20130237588 | VASCULAR THERAPEUTICS - The present invention provides a method of preventing or reducing restenosis, neointima formation, graft failure, atherosclerosis, angiogenesis and/or solid tumour growth in a subject. The method comprises administering to the subject a prophylactically effective dose of a nucleic acid which decreases the level of c-Jun mRNA, c-Jun mRNA translation or nuclear accumulation or activity of c-Jun. It is preferred that the nucleic acid is a DNAzyme that targets c-Jun mRNA. | 2013-09-12 |
20130237589 | APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS - The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders. | 2013-09-12 |
20130237590 | ASSESSING THYROID NEOPLASMS - This document provides methods and materials involved in assessing thyroid neoplasms. For example, methods and materials for using microRNA (miR) levels (e.g., miR122 levels) to determine whether a thyroid neoplasm (e.g., a follicular thyroid neoplasm) is benign or malignant as well as methods and materials for using miR levels (e.g., miR122 levels) to determine whether a malignant thyroid cancer patient is likely to have a favorable or unfavorable outcome are provided. This document also provides methods and materials involved in treating cancer. | 2013-09-12 |
20130237591 | PHARMACEUTICAL COMPOSITION FOR TREATING ADVERSE REACTIONS DUE TO ADMINISTRATION OF SPIEGELMERS - The invention relates to the use of an L-ribozyme, which is capable of splitting an L-RNA in the region of a target sequence of the L-RNA, in order to produce a pharmaceutical composition for trating undesired physiological adverse reactions due to the administration of a therapeautic modecule containing the L-RNA. Alternatively, an endogeneous target RNA may also be split by the L-ribozyme. | 2013-09-12 |
20130237592 | METHOD FOR PRODUCING A PROTEIN OF INTEREST AT THE SITE OF A CLOT - The present disclosure provides, inter alia, formulation compositions comprising modified nucleic acid molecules which may encode a protein, a protein precursor, or a partially or fully processed form of the protein or a protein precursor. The formulation composition may further include a modified nucleic acid molecule and a delivery agent. The present invention further provides nucleic acids useful for encoding polypeptides capable of modulating a cell's function and/or activity. | 2013-09-12 |
20130237593 | MULTI-SITE ADMINISTRATION - The present disclosure provides, inter alia, formulation compositions comprising modified nucleic acid molecules which may encode a protein, a protein precursor, or a partially or fully processed form of the protein or a protein precursor. The formulation composition may further include a modified nucleic acid molecule and a delivery agent. The present invention further provides nucleic acids useful for encoding polypeptides capable of modulating a cell's function and/or activity. | 2013-09-12 |
20130237594 | SPLIT DOSE ADMINISTRATION - The present disclosure provides, inter alia, formulation compositions comprising modified nucleic acid molecules which may encode a protein, a protein precursor, or a partially or fully processed form of the protein or a protein precursor. The formulation composition may further include a modified nucleic acid molecule and a delivery agent. The present invention further provides nucleic acids useful for encoding polypeptides capable of modulating a cell's function and/or activity. | 2013-09-12 |
20130237595 | ANTIBACTERIAL AGENTS: HIGH-POTENCY MYXOPYRONIN DERIVATIVES - The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein Ya, Yb, R1, R2, and G are as described in the specification, as well as compositions comprising a compound of formula (I). The compounds are useful as inhibitors of bacterial RNA polymerase and as antibacterial agents. | 2013-09-12 |
20130237596 | Uses of 15-benzylidene-14-deoxy-11,12-didehydroandrographolide Derivatives in the Preparation of Antineoplastic Drugs - The present invention relates to the preparation of anti-tumor drugs with andrographolide derivatives, which belongs to the field of pharmaceutical technology, and involves 15-benzylidene substituted derivatives of 14-deoxy-11,12-didehydro-andrographolide and their 3,19-ester derivatives. Proved by the experiments, these compounds significantly inhibited the colony formation and migration ability of various cancer cells, and also inhibited the migration ability of vascular endothelial cells in vitro. The compounds of this invention significantly inhibited the tumor growth, invasion, metastasis and angiogenesis on mouse xenograft models, and inhibited the experimental lung metastasis of B16-F10 malignant melanoma cells. Therefore, this class of compounds could be used as the active ingredients for the preparation of antineoplastic drugs, which are of efficiency and low-toxicity. Thereby it has potential to expand the selectable range of clinical drug and is of high significance to make full use of the plant resources of | 2013-09-12 |
20130237597 | EXTENDED-RELEASE SOLID ORAL DOSAGE FORM FOR HOMEOPATHIC COMPOSITIONS - Compositions including homeopathic active ingredients prepared in timed and/or extended-release dosage form are provided. In an embodiment, a time-release composition comprises an active ingredient component including at least one homeopathic component, and an excipient or carrier component including one or more hydrophilic polymers. A method for treating symptoms due to colds and/or flu is provided comprising administering an extended-release composition. | 2013-09-12 |
20130237598 | ANTIVIRAL COMPOSITIONS - This invention provides virucidally-enhanced alcoholic compositions. The compositions include at least about 50 wt. % of a C | 2013-09-12 |
20130237599 | COMPOUNDS AND USES THEREOF FOR TREATING INFLAMMATION AND MODULATING IMMUNE RESPONSES - The present invention provides compounds, and compositions comprising these compounds, which have immunomodulatory activity and/or anti-inflammatory activity. | 2013-09-12 |
20130237600 | TREATING ECZEMA AND/OR PSORIASIS - The treatment of humans or other mammals for eczema and/or psoriasis using dosage forms or compositions that include cetyl myristate alone or (in admixture or serially) both cetyl myristate and cetyl palmitate. | 2013-09-12 |
20130237601 | COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF FIRE BLIGHT - The invention relates to an agent for treating and/or preventing fire blight, particularly present in wood and fruit trees, comprising formic acid and/or a salt of formic acid, particularly calcium formiate as an active component. Further disclosed is the use of formic acid and/or a salt of formic acid, particularly calcium formiate as an active component in herbicides, particularly for treating and/or preventing fire blight, and the use of formic acid and/or a salt of formic acid, particularly calcium formiate, for the production of an agent for treating and/or preventing fire blight. | 2013-09-12 |
20130237602 | VALPROIC ACID DRUG DELIVERY SYSTEMS AND INTRAOCULAR THERAPEUTIC USES THEREOF - Biocompatible, bioerodible, sustained release drug delivery system formulated as implants, microspheres and high viscosity hyaluronic acid solutions comprise valproic acid as therapeutic agent and a biodegradable polymer, the system being effective, when placed intraocular (such as into the subtenon space or into the vitreous) to treat a retinal disease or condition. | 2013-09-12 |
20130237603 | Acetylcysteine Compositions and Methods of use Thereof - A pharmaceutical composition and method for providing a reduction in side effects for human patients in need of therapy comprising the administration of a pharmaceutical composition comprising acetylcysteine is disclosed. | 2013-09-12 |
20130237604 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS - Embodiments of the invention relate to methods and compositions for treating symptoms related to inflammatory conditions and to methods and compositions for treating inflammatory components of common cold, utilizing various method of administration of X-ray contrast media (CM). | 2013-09-12 |
20130237605 | COMPOSITIONS, METHODS, AND KITS FOR REGULATING ENERGY METABOLISM - The present invention provides for compositions, methods and kits for regulating energy metabolism. In one aspect, the invention provides for compositions that comprise a combination of (a) branched chain amino acids, such as leucine, and (b) vitamin B6, or any precursors or metabolites of (a) or (b). These combinations may be synergistic and/or effective for reducing weight or adipose volume. In another aspect, the invention provides for methods of regulating energy metabolism by the administration of one or more compositions comprising branched chain amino acids and vitamin B6. The invention also provides for kits comprising compositions of branched chain amino acids and vitamin B6 packaged in an oral dose form with usage instructions. | 2013-09-12 |
20130237606 | OPHTHALMIC AND CONTACT LENS SOLUTIONS USING CHOLINE - The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: | 2013-09-12 |
20130237607 | TREATMENT OF CONNECTIVE TISSUE DISEASES OF THE SKIN - The present invention provides effective and safe medicaments for the treatment of connective tissue diseases of the skin, particularly with respect to the treatment of cutaneous forms of Lupus Erythematous. The medicaments comprise as the therapeutically active ingredient a beta | 2013-09-12 |
20130237608 | Prolonged Release Pharmaceutical Composition Containing 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)Phenol - A pharmaceutical formulation for prolonged release of the active ingredient 3-(3-dimethylamino-1-ethyl-2-methylpropyl)phenol or a pharmaceutically acceptable salt thereof in a matrix containing between 1 and 80 wt. % of at least one pharmaceutically acceptable hydrophilic or hydrophobic polymer as a matrix forming agent and exhibiting in vivo the following release rate: 3 to 35% by weight (based on 100% by weight active ingredient) 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol released after 0.5 hours; 5 to 50% by weight 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol released after 1 hour; 10 to 75% by weight 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol released after 2 hours; 15 to 82% by weight 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol released after 3 hours; 30 to 97% by weight 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol released after 6 hours; more than 50% by weight 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol released after 12 hours; more than 70% by weight 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol released after 18 hours, and more than 80% by weight 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol released after 24 hours. | 2013-09-12 |
20130237609 | CELLULOSE DERIVATIVES FOR ENHANCING BIOAVAILABILITY OF FLAVONOIDS - The present invention relates to delivery systems to enhance the bioavailability of flavonoids to improve human health. Flavonoids of interest include but are not limited to curcumin, resveratrol, ellagic acid, naringenin, and quercetin. Flavonoids are important in part because they are known to have beneficial effects on human health, including cardioprotective, antioxidant, and anticancer effects. Utility has been limited by low bioavailability, both in the sense of requiring high doses and in that it has been difficult to carry out proper dose-response studies in the absence of methods to control the actual dose administered. In addition to pharmaceutical applications, there are potential nutraceutical uses, for example in supplements that might be sold in health food stores and pharmacies. | 2013-09-12 |
20130237610 | DYNAMIC BALANCING OF AUTONOMIC NERVOUS SYSTEM THROUGH VITAMIN MK-7 - Sympathovagal balance is essential in maintaining internal homeostasis. Imbalance in this can lead to many disease conditions such as cardiovascular diseases, type 2 diabetes mellitus, high blood pressure, gastroesophageal reflux disease (GERD), IBS, depression, COPD, etc. Sudden cardiac death and Myocardial infarction are result of autonomic dysfunction. Many drugs have been proposed for these conditions but lack in correcting the condition and can themselves produce side effects, such as prolongation of QT interval. Inventors of current invention observed serendipitously that vitamin MK-7 can restore the sympathovagal balance and also have cardio protective effect by shortening of QT interval and prolongation of RR interval. Further to this, it was also observed that vitamin MK-7 improves cardiac output, left ventricular work, HDL cholesterol and reduces blood sugar. | 2013-09-12 |
20130237611 | AQUEOUS FORMULATIONS OF (2-HYDROXYMETHYL-INDANYL-4-OXY)-PHENYL-4,4,4-TRIFLUOROBUTANE-1-SULFONATE - The invention relates to aqueous formulations containing (−)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl 4,4,4-trifluorobutane-1-sulfonate. Said formulations are suitable as infusion solutions or as concentrate for producing these infusion solutions. | 2013-09-12 |
20130237612 | LEUCINE BETA ROLL DOMAINS AND USES THEREOF - In one aspect, the invention relates to a peptide that forms a calcium-dependent hydrogel using a rationally engineered beta roll peptide. In the absence of calcium, the peptide is intrinsically disordered. Upon addition of calcium, the peptide forms a corkscrew-like structure. In one embodiment, one face of the beta roll is mutated to comprise leucine residues. In some embodiments, a leucine zipper forming helical domain to the engineered beta roll forms hydrogels by physical cross-linking in calcium rich environments. | 2013-09-12 |
20130237613 | SUGAR-BASED SURFACTANT MICROEMULSIONS CONTAINING ESSENTIAL OILS FOR COSMETIC AND PHARMACEUTICAL USE - The present invention relates to a thermodynamically stable, biocompatible, environment friendly, and temperature-insensitive microemulsion containing various botanical essential oils, sugar based surfactants, polyhydric alcohols, and an aqueous phase. | 2013-09-12 |
20130237614 | BIORESORABLE POLYMER MATRICES AND METHODS OF MAKING AND USING THE SAME - A kit for forming a bioerodible composition is provided with a first aliquot portion of a reaction mixture having an aldehydic polymer solution, and a second aliquot portion of a reaction mixture having solids which include a cross-linking hydrazide. When mixed, the first and second aliquot portions of the reaction mixture react at a pH of 4 to 6 to form a solidified bioerodible composition within about 1 to about 10 minutes, to form a hydrazide cross-linked aldehydic polymer matrix. The bioerodable composition may be usefully employed to seal and/or treat wounds (e.g., a surgical incision). | 2013-09-12 |
20130237615 | PROCESS OF PREPARING A CROSSLINKED GEL - The subject of the present invention is a process of preparing a crosslinked gel of at least one polysaccharide or one of its salts, including at least the steps consisting in: a) providing, at a temperature below 35° C., an aqueous gel including at least one polysaccharide in an uncrosslinked form together with at least one difunctional or multifunctional epoxy crosslinking agent; b) maintaining the mixture of step a) at a temperature below 35° C. for at least one hour; c) stimulating the crosslinking reaction of the mixture obtained after step b), and if need be; d) recovering said crosslinked gel formed. | 2013-09-12 |
20130237616 | MODIFIED ALKOXYLATION PRODUCTS HAVING AT LEAST ONE NON-TERMINAL ALKOXYSILYL GROUP AND A PLURALITY OF URETHANE GROUPS, AND THEIR USE - Alkoxylation products, their preparation, compositions comprising these alkoxylation products, and the use thereof as or for producing adhesives and sealants. | 2013-09-12 |
20130237617 | PROCESS FOR PRODUCING A METHANE-CONTAINING GAS FROM SYNTHESIS GAS AND METHANE PRODUCTION PLANT FOR CARRYING OUT THE PROCESS - The invention relates to a process for producing a methane-containing gas from synthesis gas, wherein a synthesis gas containing carbon monoxide and hydrogen is fed for methanation to a reactor system ( | 2013-09-12 |
20130237618 | PROCESS FOR PRODUCING METHANOL - An object of the invention is to provide a methanol production process which can efficiently produce methanol from carbon dioxide and hydrogen while suppressing loads to the global environment. The process for producing methanol of the invention includes a step (a) of reacting hydrogen and carbon dioxide with each other in a reactor in the presence of a copper-containing catalyst to produce a reaction mixture containing methanol; a step (b) of circulating part or all of the reaction mixture to the step (a); a step (c1) of combusting part of the reaction mixture to produce a combustion product and energy, and a step (c2) of circulating part or all of the combustion product to the step (a), the step (c1) and the step (c2) being performed when the reaction mixture contains a compound (p) containing carbon and hydrogen except methanol at not less than 0.1 mol % (wherein all components of the reaction mixture excluding methanol and water represent 100 mol %); and a step (d) of separating a component including methanol from the reaction mixture. | 2013-09-12 |
20130237619 | PBI MODIFICATION AND CROSS-LINKING METHODS - The present invention relates to a method for modifying and cross-linking polybenzimidazoles, PBI. The polybenzimidazole reacts with a compound, which has a halogen and a double bond functionality and which comprises a halogen and an organic group to form modified polymers by means of a nucleophilic substitution of the amine proton of the benzimidazole functionality in a solution, and a functional group is connected via each resulting free double bond and/or the polymers that are thus modified are cross-linked. | 2013-09-12 |
20130237620 | COMPOSITIONS AND METHODS FOR RECYCLING PLASTICS COMPRISING POLYMERS VIA SOLVENT TREATMENT - Compositions containing a turpentine liquid and methods are disclosed for dissolving, dissolving via melting, selectively dissolving via melting, decomposing plastic comprising a chlorine-containing polymer or thermosetting polymer, and/or co-dissolving plastic with fossil fuel for purifying, separating, recovering or recycling plastic-containing material. | 2013-09-12 |
20130237621 | HIGH HEAT RADIATION COMPOSITE AND A METHOD OF FABRICATING THE SAME - The present disclosure provides a high heat radiation composite material including a hybrid filler comprising expanded graphite filled with expandable polymeric beads, and a fabrication method thereof. In the method, a dispersion solution is prepared by dispersing expandable polymeric beads in ethanol. Expanded graphite is immersed in the dispersion solution, and heat-treated to remove ethanol, thereby producing the hybrid filler. The hybrid filler is dispersed into the matrix polymer via an extrusion/injection process, thereby producing the composite material. | 2013-09-12 |
20130237622 | METHOD OF PRODUCING A FLEXIBLE POLYURETHANE FOAM ARTICLE - A flexible polyurethane foam article exhibiting flame resistance comprises the reaction product of an isocyanate and an isocyanate-reactive component comprising a polyol reactive with the isocyanate. The isocyanate and the isocyanate-reactive component are reacted in the presence of a blowing agent and a phospholene oxide. A method of producing the flexible polyurethane foam article includes the step of reacting the isocyanate and the isocyanate-reactive component in the presence of the blowing agent and an effective amount of the phospholene oxide to form the flexible polyurethane foam article which is flame resistant. | 2013-09-12 |
20130237623 | MONOHYDROXY CYCLIC PHOSPHONATE SUBSTANTIALLY FREE OF POLYHYDROXY PHOSPHONATE, PROCESS FOR MAKING SAME AND FLAME RETARDANT FLEXIBLE POLYURETHANE FOAM OBTAINED THEREFROM - A monohydroxy cyclic phosphonate substantially free of polyhydroxy phosphonate is employed as a reactive flame retardant in flexible polyurethane. | 2013-09-12 |
20130237624 | METHOD FOR PRODUCING FLEXIBLE POLYURETHANE FOAMS - The present invention relates to a method for producing flexible polyurethane foams, wherein a polyol component which comprises polyricinoleic acid esters is used as starting substance. The flexible polyurethane foams according to the invention have a bulk density according to DIN EN ISO 3386-1-98 in the range of ≧10 kg/m | 2013-09-12 |
20130237625 | BIODEGRADABLE ELASTOMERS PREPARED BY THE CONDENSATION OF AN ORGANIC DI-, TRI- OR TETRA-CARBOXYLIC ACID AND AN ORGANIC DIOL - The present disclosure relates to biodegradable and biocompatible elastomeric polymers that are amorphous and have a glass transition temperature below both room temperature and body temperature, and which will homogenously degrade to water soluble by-products with no reported toxicity. | 2013-09-12 |
20130237626 | D1479 STABLE LIQUID BAP PHOTOINITIATOR AND ITS USE IN RADIATION CURABLE COMPOSITIONS - The invention relates to radiation curable compositions comprising a liquid 0/s(acyl)phosphine photo initiators of formula (I): wherein each of Ar | 2013-09-12 |
20130237627 | CROSSLINKABLE CURING SUPER-BRANCHED POLYESTER AND CURED PRODUCT AND PREPARATION METHOD THEREOF - A crosslinkable curing super-branched polyester and the cured product and the preparation method thereof are disclosed. The super-branched polyester has high refractive index and comprises a compound represented by the following structural formula (I). In the formula (I), HBP is the backbone of the super-branched polyester; both a and b are positive integers; the sum of a and b is less than or equal to n; n is more than or equal to 10 and less than 80. In the super-branched polyester, A is represented by formula (II) and N is represented by formula (III), wherein R is methyl or hydrogen atom; the mole ratio of N relative to the total mole of A and N is more than 30 mol %, and the ratio of the total mole of A and N relative to the product of the total mole of HBP backbone and n is more than 0.5 and less than or equal to 1. | 2013-09-12 |
20130237628 | LOW-EXTRACTABLE THIOXANTHONES - 3-Esters and 3-amides of thioxanthone bearing alkyl chains of appropriate length and can be used as photoinitiators or sensitizers in photopolymerizable systems, in particular for the preparation of coatings compatible with the food use. | 2013-09-12 |
20130237629 | CURABLE RESIN COMPOSITION - The present invention is a curable resin composition comprising a copolymer (A) represented by the following general formula (1), silica fine particles (B), a reactive monomer (C) and a polymerization initiator (D). In the general formula (1), X is an atomic group formed by removing “k” mercapto groups from a multifunctional thiol compound having at least “k” mercapto groups; Y is a monovalent organic group derived from a copolymer formed by copolymerizing unsaturated monomers; and “k” is an integer of 3 to 10. The present invention can provide a hard coat agent which has low curing shrinkage and which has both low curing shrinkage and antiblocking properties as needed; a hard coat film and a hard-coat treated plastic substrate having high pencil hardness and low curling properties, by using this hard coat agent. | 2013-09-12 |
20130237630 | SEMI-CURED PRODUCT, CURED PRODUCT AND METHOD OF MANUFACTURING THESE, OPTICAL COMPONENT, CURABLE RESIN COMPOSITION - A heat-resistant cured product is efficiently produced by obtaining a semi-cured product where a curable resin composition containing a (meth)acrylate monomer, a non-conjugated vinylidene group-containing compound and a thermal radical-polymerization initiator is processed by at least one of photoirradiation and heating to give a semi-cured product having a complex viscosity of from 10 | 2013-09-12 |
20130237631 | BIOMEDICAL DEVICES CONTAINING INTERNAL WETTING AGENTS - This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer. | 2013-09-12 |
20130237632 | SHAPE MEMORY POLYMER MEDICAL DEVICE - Methods and apparatus described herein may utilize activation of an SMP material to install medical devices with respect to a surgical site. Activation of the SMP material may be performed with the use of a triggering force and/or a constraint applied to the SMP material. Activation using a triggering force and/or a constraint may be used to create varied activation rates in an SMP material and varying speeds and times of activation to occur in shape memory polymers in devices. The disclosure also describes devices using wedge elements for activation of shape memory response in the SMP material. | 2013-09-12 |
20130237633 | COMPOSITE MATERIAL FROM WASTE AND AT LEAST ONE ELEMENT OF VULCANIZED RUBBER AND TIRE CORDS - The subject matter discloses a composite material comprising a first component and a second component, the first component comprising an organic element and a thermoplastic element and the second component comprising at least one element selected from the group consisting of vulcanized rubber and tire cords. The subject matter further discloses a process comprising mixing while heating under shear forces a first component comprising organic waste and thermoplastic waste with a second component comprising at least one element selected from the group consisting of vulcanized rubber and tire cords; to obtain a melt; processing the melt, the processing comprises at least cooling the melt to obtain a composite material comprising: organic element; thermoplastic element; and at least one element selected from the group consisting of vulcanized rubber and tire cords. | 2013-09-12 |
20130237634 | Two-Component Mortar Composition and its Use - A description is given of a two-component mortar composition having a curable resin component having a content of at least one free-radically polymerizable resin, fillers, accelerators, stabilizers and optionally further conventional mortar constituents and a hardener component which is arranged separately therefrom to inhibit reaction and has a content of at least one peroxide for chemical fastening of anchoring means in boreholes, which is characterized in that the resin component contains from 0.1 to 0.5% by weight of at least one accelerator and from 0.003 to 0.03% by weight of at least one stabilizer and the hardener component contains from 0.1 to 0.35% by weight of organic peroxide, in each case based on the total weight of resin component and hardener component, and also the use of this two-component mortar composition for chemical fastening of anchoring means in boreholes. | 2013-09-12 |
20130237635 | Lignite-Based Foundry Resins - Described herein, in the preferred embodiment, is a leonardite-based polyurethane resin binder that may be used, among other applications, as a binder in combination with foundry aggregate, e.g., sand, for molding or casting metal parts. The binders described herein comprise a humic substance, preferably leonardite, combined with a polymerizable polyol, an isocyanate, and a polymerization catalyst to make a polyurethane resin binder in situ in a foundry aggregate, such as sand. The lignite is mixed with the polymerizable polyol and dispersing agents as additives to improve the suspension quality and binder performance of the lignite-containing part of the binder components. | 2013-09-12 |
20130237636 | Additive Process for Production of Dimensionally Stable Three Dimensional Objects - Generally, compositions and methods of producing dimensionally stable three dimensional objects using an additive build up process. Specifically, materials combinable in an additive build up process using a materials printer for the production of stable three dimensional molds useful in the production of molded or formed parts. | 2013-09-12 |
20130237637 | METHOD FOR MANUFACTURING RUBBER COMPOSITION - The present invention provides a method for producing a rubber composition containing a rubber component (A) of at least one selected from natural rubbers and synthetic dienic rubbers, an inorganic filler (B), a silane coupling agent (C) and an acidic compound (D), wherein the rubber composition is kneaded in multiple stages, and in the final stage of kneading, the acidic compound (D) is added, and the highest temperature of the rubber composition in the final stage of kneading is from 60 to 120° C. The production method enables production of a rubber composition having a low-heat-generation property while successfully preventing the coupling function activity of the silane coupling agent from lowering. | 2013-09-12 |
20130237638 | LOW TEMPERATURE, MOISTURE CURABLE COATING COMPOSITIONS AND RELATED METHODS - Low temperature, moisture curable coating compositions, related coated substrates, and methods for coating a substrate are described. The coating compositions include an ungelled, secondary amine-containing Michael addition reaction product of reactants including a compound comprising more than one site of ethylenic unsaturation, and an aminofunctional silane. | 2013-09-12 |
20130237639 | CURABLE RESIN COMPOSITION, CURED PRODUCT THEREOF, PHENOLIC RESIN, EPOXY RESIN, AND SEMICONDUCTOR SEALING MATERIAL - A high degree of resistance to moisture and solder and high flame retardancy are realized without incorporating a halogen in view of environmental friendliness. A phenolic resin has structural moieties which are a naphthylmethyloxy group- or anthrylmethyloxy group-containing aromatic hydrocarbon group (ph1), a phenolic hydroxyl group-containing aromatic hydrocarbon group (ph2), and a divalent aralkyl group (X) represented by general formula (1) below: | 2013-09-12 |
20130237640 | Process for preparing a vinylidene chloride polymer latex - A process for preparing a seed latex of an epoxy-containing polymer by radical polymerization in aqueous emulsion of at least one epoxy-containing monomer and optionally at least one comonomer is disclosed. | 2013-09-12 |
20130237641 | PROCESS USING BISPHENOL A AMINATED AND ALKOXYLATED DERIVATIVE AS DEMULSIFIER - Embodiments of the present disclosure include a method of destabilizing a crude oil-water emulsion that includes adding to the crude oil-water emulsion a demulsifier obtained by an alkoxylation reaction of an aminated epoxy adduct, the aminated epoxy adduct obtained by a reaction of an epoxy resin and an amine. In one or more embodiments, the alkoxylation reaction includes reacting C2 to C4 alkylene oxides with the aminated epoxy adduct. | 2013-09-12 |
20130237642 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM - A thermosettable (curable) epoxy resin composition including (A) a residual oligomeric product; wherein the residual oligomeric product comprises a polyfunctional aliphatic or cycloaliphatic epoxy resin which has been isolated from an epoxy resin product formed as a result of an epoxidation process comprising the reaction of (i) an aliphatic or cycloaliphatic hydroxyl-containing material with (ii) an epihalohydrin, (iii) a basic-acting substance, (iv) a non-Lewis acid catalyst, and (V) optionally one or more solvents; (B) an epoxy curing material comprising (i) an epoxy resin curing agent, (ii) an epoxy resin catalyst, or both an epoxy resin curing agent (i) and an epoxy resin catalyst (ii); and (C) optionally, an epoxy resin compound other than the aliphatic or cycloaliphatic polyfunctional epoxy resin (A). A thermoset may also be made from the above thermosettable composition. | 2013-09-12 |
20130237643 | D1364 BT SECONDARY COATINGS ON OPTICAL FIBER - The invention relates to a Radiation Curable Secondary Coating composition for use on an Optical Fiber. The Radiation Curable Secondary Coating composition is a urethane-free Alpha Oligomer prepared by reaction of the following: (a) an acrylate compound selected from an alcohol-containing acrylate or alcohol-containing methacrylate compound, (b) an anhydride compound, (c) an epoxy-containing compound, (d) optionally an extender compound, and (e) optionally a catalyst. The invention also relates to a coated wire and to a coated optical fiber. | 2013-09-12 |
20130237644 | COPIER/PRINTER EXTERIOR PART USING HALOGEN-FREE FLAME-RETARDANT RESIN COMPOSITION INCLUDING RECYCLED POLYCARBONATE AND RECYCLED POLYETHYLENE TEREPHTHALATE - A copier/printer exterior part uses a halogen-free flame-retardant resin composition. The halogen-free flame-retardant resin composition includes 5 wt % to 50 wt % of unused polycarbonate, 20 wt % to 63 wt % of recycled polycarbonate, 5 wt % to 35 wt % of recycled polyethylene terephthalate, 0.2 wt % to 2 wt % of a styrene-acrylonitrile-glycidyl methacrylate terpolymer, 5 wt % to 15 wt % of a toughener, 10 wt % to 20 wt % of a flame retardant, 0.1 wt % to 0.8 wt % of a flame-retardant antidrip agent, 0.1 wt % to 1 wt % of an antioxidant, and 0.1 wt % to 2 wt % of a lubricant. The styrene-acrylonitrile-glycidyl methacrylate terpolymer includes 1 wt % to 5 wt % of glycidyl methacrylate and 20 wt % to 33 wt % of acrylonitrile. | 2013-09-12 |
20130237645 | THERMOSETTING RESIN COMPOSITION, METHOD OF MANUFACTURING THE SAME AND CIRCUIT BOARD - The invention relates to a thermosetting resin composition which includes a metal filler component, a fluxing component and a thermosetting resin binder. The metal filler component includes at least one of bismuth (Bi) and indium (In), and tin (Sn). The fluxing component, which at least one of a compound of structural formula (1) below and a compound of structural formula (2) below, is used. | 2013-09-12 |
20130237646 | THERMOREVERSIBLY CROSS-LINKED GRAFT POLYMERS - A graft polymer PG includes a polymer backbone P and at least one side graft G linked to the polymer backbone, the graft G having the general formula (1): in which R | 2013-09-12 |
20130237647 | STRAW PLASTIC AND PREPARATION METHOD THEREOF - A straw plastic and the preparation method thereof are disclosed, wherein the crops straw with the length of 1.5˜2.0 mm is dried and mixed with plastic and plastic additive, and then extruded and palletized with twin screw extruder. The granular material of the invention has even particle size and stable state, and can be made into film, sheet or injection moulded product with molding process such as blow molding, drawing or injection molding. The product appears the color of natural wood, has the texture of plant fiber on the surface, and has good surface finish, high strength, good toughness, and comfortable hand feeling. The invention reduces the environmental pollution resulted from the discarding of undegradable plastic and achieves the full utilization of resource. | 2013-09-12 |
20130237648 | COMPATIBILIZED COMPOSITION, METHOD FOR THE FORMATION THEREOF, AND ARTICLE COMPRISING SAME - A poly(phenylene ether)-poly(hydroxy ether) block copolymer is used to compatibilize blends of polar polymers and non-polar polymers. The resulting compatibilized blends exhibit physical property improvements relative to blends without a compatibilizer and blends with a poly(hydroxy ether). | 2013-09-12 |
20130237649 | RESIN COMPOSITION, AND FILM, PLATE AND INJECTION-MOLDED ARTICLE OBTAINED BY MOLDING THE SAME - The present invention relates to a resin composition which includes: a polycarbonate resin (A) that contains structural units (a) derived from a dihydroxy compound having the portion represented by the following formula (1) as part of the structure thereof; and a flame retardant (B) that contains phosphorus and nitrogen, wherein a test specimen produced from the resin composition in accordance with JIS K7110 has an Izod impact strength of 5.0 kJ/m | 2013-09-12 |
20130237650 | Flame-Retardant and Scratch-Resistant Polycarbonate Resin Composition - The present invention provides a flame-retardant and scratch-resistant polycarbonate resin composition including a (meth)acrylic flame-retardant copolymer. | 2013-09-12 |
20130237651 | Viscosity Suppression of Associative Thickeners Using Organophosphates - The viscosity of solutions of nonionic synthetic associative thickeners is controlled by adding organophosphates to the solution of associative thickeners. The associative thickeners are hydrophobically modified polymers and the organophosphates include one or more hydrophobic groups. | 2013-09-12 |
20130237652 | BIMODAL POLYETHYLENE COMPOSITION FOR INJECTION MOULDED ARTICLES - Bimodal high density polyethylene composition for producing moulded articles comprising —an ethylene homopolymer or an ethylene alpha-olefin copolymer which is a bimodal high density polymer (COMPONENT A) in combination with —an alphanucleating agent (COMPONENT B), —a slip agent being a primary fatty acid amide, (COMPONENT C) and —one or more additives selected from antioxidants, acid scavengers, pigments and UV-stabilisers (COMPONENT D), the composition showing an increased the crystallisation temperature and a decreased coefficient of friction compared to a bimodal HDPE composition prepared with the sole use of nucleating agent and compared to the sole use of a slip agent; and its use for producing injection moulded articles, especially caps and closures. | 2013-09-12 |
20130237653 | RUBBER COMPOSITION FOR TIRE TREAD - A rubber composition for a tire tread contains styrene-butadiene rubber in a compounding amount of 100 parts by weight, silica in a compounding amount of 90 to 170 parts by weight, and an aromatic modified terpene resin in a compounding amount of 10 to 30 parts by weight. The styrene-butadiene rubber contains 40 to 100% by weight of solution-polymerized styrene-butadiene rubber (S-SBR1) and 60 to 0% by weight of solution-polymerized styrene-butadiene rubber (S-SBR2), the total content thereof being 100% by weight. The S-SBR1 has a styrene content of 30 to 38% by weight and a vinyl content of 60 to 80% by weight, the total content thereof being 100% by weight, a glass transition temperature of −20 to −5° C., and a weight average molecular weight of 1,000,000 to 1,800,000. | 2013-09-12 |
20130237654 | Anti-Foaming Agents for Hot-Melt Adhesives - A polyamide hot melt adhesive composition is described comprising the polyamide condensation product of substantially equimolar quantities of: (a) an acid component consisting essentially of one or more polymeric fatty acids and one or more dicarboxylic acids, and (b) an amine component consisting essentially of one or more cyclic aliphatic diamines, one or more non-cyclic aliphatic diamines in which the amine groups are bonded to odd-numbered carbon atoms on the aliphatic chain, and one or more alkylene diamines, and (c) an anti-foaming or defoaming agent comprised of a water based silicone compound comprising 5% solids in water wherein the defoaming agent reduces or eliminates foaming occurring during the condensation reaction providing the condensation product and (d) an acid based catalyst. | 2013-09-12 |
20130237655 | Composition Comprising Propylene-Alpha-Olefin Copolymer, Olefin Block Copolymer and DPO-BSA Molecular Melt - Compositions comprising (A) propylene-alpha-olefin copolymer, (B) olefin block copolymer, and (C) DPO-BSA molecular melt (MM) are useful in the preparation of the top skin layer of artificial leather multi-layer structures. | 2013-09-12 |
20130237656 | LOW VOC SOLVENTBORNE DISPERSION COMPOSITIONS FOR TINTING SOLVENT-BASED COATINGS - A solventborne pigment dispersion having a volatile organic chemical (VOC) content that is less than 250 g/L for tinting solvent-based surface coatings is formulated using a vegetable oil-derived solvent component that is one or more methyl esters of vegetable oils, an acrylic resin containing at least 60% solids, one or more highly concentrated surfactants containing up to 100% by weight of active constituents and that contains no PMA or free aromatic moieties, and one or more organic pigments or one or more inorganic pigment, or a combination thereof. | 2013-09-12 |
20130237657 | PROCESS FOR MANUFACTURING CALCIUM CARBONATE MATERIALS HAVING A PARTICLE SURFACE WITH IMPROVED ADSORPTION PROPERTIES - The invention relates to a process for manufacturing calcium carbonate materials having a particle surface with improved adsorption properties of dispersant, using at least one lithium ion-containing compound, the calcium carbonate material obtained by this process, the use of the calcium carbonate materials in paper, paints and plastics, as well as the use of the lithium ion-containing compounds in the manufacturing process. | 2013-09-12 |
20130237658 | RESIN COMPOSITION - Provided is a resin composition that includes calcium carbonate contained in a polyester resin, a polyamide resin, or at thermosetting resin and that achieves good moldability. The resin composition includes calcium carbonate having a pB ranging from | 2013-09-12 |
20130237659 | PNEUMATIC TIRES FOR COMMERCIAL VEHICLES - A pneumatic tire for a commercial vehicle with a tread, wherein at least the part of the tread which comes into contact with the road contains a sulphur-vulcanized rubber mixture. The sulphur-vulcanized rubber mixture contains 90 to 50 phr (parts by weight, based on 100 parts by weight, of all of the rubbers in the mixture) of natural rubber, 10 to 50 phr of at least one polybutadiene having a glass transition temperature T | 2013-09-12 |
20130237660 | (METH)ACRYLATE COMPOSITION - Provided is a (meth)acrylate composition containing: (A) at least one (meth)acrylate compound selected from the group consisting of a (meth)acrylate-modified silicone oil, a (meth)acrylate having a long-chain aliphatic hydrocarbon group, and a polyalkylene glycol (meth)acrylate having number-average molecular weight of not less than 400; (B) a (meth)acrylate compound to which an alicyclic hydrocarbon group having 6 or more carbon atoms is ester-linked; (C) (meth)acrylic acid or a (meth)acrylate compound having a polar group; (D) a radical polymerization initiator; and (E) a white pigment. | 2013-09-12 |